{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:19:39Z","timestamp":1790738379698,"version":"4.1.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to ascertain the unique metabolic profile of exhaled breath condensate (EBC) samples in pulmonary aspergillosis (PA) patients, and explore their usefulness for the diagnosis of PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 133 patients were included in the study, including 66 PA patients (invasive pulmonary aspergillosis, n=3; chronic pulmonary aspergillosis, n=60; allergic bronchopulmonary aspergillosis, n=3) and controls (n=67). Ultra high-performance liquid chromatography coupled with high-resolution mass spectrometry(UHPLC-HRMS) was used to analyze EBC samples. Metabolic profiling of EBC samples that were collected from 22 CPA patients at various times during treatment (before treatment, &amp;lt;1 month, 1\u20132 months, 2\u20133 months, 3\u20136 months, and \u22656 months after treatment initiation) were performed using UHPLC-HRMS. Potential biomarkers were evaluated using cluster analysis, Venn diagram and receiver operating characteristic analysis (ROC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 47 metabolites of potential interest were detected in the EBC samples. Further investigation showed that Asperpyrone C, Kotanin, Terphenyllin, Terrelumamide B, and Cyclotryprostatin D could be used as a diagnostic biomarker for PA. The classification between metabolic profiling of EBC samples from PA patients and controls was good with a sensitivity of 100%, specificity 89.6% for patients with PA, respectively. Venn diagram analysis of these biomarker candidates displayed three main types of compounds, which could be used for the further discrimination of aspergilloma and chronic cavitary PA. In addition, antifungal treatment had a limited influence on the value of the EBC results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This metabolomic approach using UHPLC-HRMS could be used as a noninvasive method for the diagnosis of PA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2022.1008924","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:51:59Z","timestamp":1662598319000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolomic profiling of exhaled breath condensate for the diagnosis of pulmonary aspergillosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuo","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.cmi.2017.09.018","article-title":"Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients","volume":"24","author":"Bhimji","year":"2017","journal-title":"Clin. Microbiol. Infection"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/10\/3\/036008","article-title":"eNose technology can detect and classify human pathogenic moldsin vitro: a proof-of-concept study ofAspergillus fumigatus and rhizopus oryzae","volume":"10","author":"de Heer","year":"2016","journal-title":"J. Breath Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5664\/jcsm.4358","article-title":"Diagnostic capability of biological markers in assessment of obstructive sleep apnea: A systematic review and meta-analysis","volume":"11","author":"De Luca Canto","year":"2015","journal-title":"J. Clin. Sleep Med. Jcsm Off. Publ. Am. Acad. Sleep Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1513\/AnnalsATS.201811-766OC","article-title":"Diagnosis of fungal infections. a systematic review and meta-analysis supporting American thoracic society practice guideline","volume":"16","author":"Haydour","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1600965","DOI":"10.1183\/13993003.00965-2016","article-title":"A European respiratory society technical standard: exhaled biomarkers in lung disease","volume":"49","author":"Horv\u00e1th","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2147\/IDR.S235182","article-title":"Metagenomic next-generation sequencing versus traditional pathogen detection in the diagnosis of peripheral pulmonary infectious lesions","volume":"13","author":"Huang","year":"2020","journal-title":"Infection Drug Resistance"},{"key":"B9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3109\/13693786.2012.682228","article-title":"Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis","volume":"50","author":"Izumikawa","year":"2012","journal-title":"Med. Mycol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2217\/bmm.13.129","article-title":"Biomarker for invasive aspergillosis: the challenges continue","volume":"8","author":"Johnson","year":"2014","journal-title":"Biomarkers Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2011.12.970","article-title":"Fungi and allergic lower respiratory tract diseases","volume":"129","author":"Knutsen","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.rmed.2013.04.007","article-title":"The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis","volume":"107","author":"Kono","year":"2013","journal-title":"Respir. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/cid\/ciu725","article-title":"A breath fungal secondary metabolite signature to diagnose invasive aspergillosis","volume":"59","author":"Koo","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"016011","DOI":"10.1088\/1752-7163\/aa5a8a","article-title":"Biomarkers in adult asthma: a systematic review of 8-isoprostane in exhaled breath condensate","volume":"11","author":"Peel","year":"2017","journal-title":"J. Breath Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01821-18","article-title":"Utility of serum and bronchoalveolar lavage fluid galactomannan in diagnosis of chronic pulmonary aspergillosis","volume":"57","author":"Sehgal","year":"2019","journal-title":"J. Clin. Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jinf.2014.01.005","article-title":"Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis","volume":"68","author":"Shin","year":"2014","journal-title":"J. Infect."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17031110","article-title":"Exhaled breath analysis in diagnosis of malignant pleural mesothelioma: Systematic review","volume":"17","author":"T\u00f6reyin","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID - ECMM - ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infection"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1008924\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:52:07Z","timestamp":1662598327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1008924\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":19,"alternative-id":["10.3389\/fcimb.2022.1008924"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1008924","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"1008924"}}